14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Tue, 21 May 2024

Trading levels for NVAX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 14.88 14.35 %
R2 14.33 10.15 %
R1 13.99 7.56 %
Current price: 13.01
Support S1 12.90 -0.84 %
S2 12.56 -3.44 %
S3 12.02 -7.64 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 14.40 10.68 %
R2 13.48 3.61 %
R1 13.11 0.769 %
Current price 13.01
Support S1 12.90 -0.85%
S2 0 .
S3 0 .

NVAX Predictions History

3 years ago
Moe A predicted that NVAX for 2021-03-12 is going $237.50 (17.13%)

Rank:

3 years ago
jjsheets330 predicted that NVAX for 2021-03-12 is going $285.00 (51.89%)

3 years ago
Diamond predicted that NVAX for 2021-03-12 is going $169.28 (-9.78%)

3 years ago
JS predicted that NVAX for 2021-03-04 is going $195.20 (23.47%)

3 years ago
vbogdan94 predicted that NVAX for 2021-03-04 is going

Rank:

3 years ago
JS predicted that NVAX for 2021-02-26 is going $234.86 (1.57%)

3 years ago
hilaryclarefarlow.217446 predicted that NVAX for 2021-02-26 is going

Rank:

3 years ago
JS predicted that NVAX for 2021-02-18 is going $277.33 (4.54%)

3 years ago
chris kenmore predicted that NVAX for 2021-02-18 is going $265.00 (-3.28%)

Rank:

3 years ago
JS predicted that NVAX for 2021-02-01 is going $208.09 (-22.44%)

Click to get the best stock tips daily for free!

About Novavax Inc

Novavax Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical tria... NVAX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT